Feb 22, 2019 - Merck (MRK) to buy Immune Design for $300 million. FDA grants priority review to regulatory applications filed by Merck, Roche (RHHBY) and AbbVie (ABBV).
Feb 20, 2019 - Novo Nordisk (NVO) clinches the FDA approval for its biologics license application in favor of Esperoct to treat adults and children suffering haemophilia A.
Feb 13, 2019 - Novo Nordisk reported full year results for 2018, and while revenue was still stagnant, earning per share could grow 4%.Due to the launch of new products like Saxenda, Ozempic, and Oral Semaglutide, N
Sector: Health Care > Industry: Major Pharmaceuticals